As a common pathogeny of pediatric pneumonia and bronchitis, an efficient replication of the respiratory syncytial virus (RSV) can be ensured by mediating cell cycle arrest via increasing transforming growth factor-β (TGF-β) and MAPK signaling pathway [52]. The gene discussed is TGFB1; the disease is susceptibility to pneumonia measurement.